诺和诺德 2025 H1:司美格鲁肽大卖 166 亿美元,中国区收入 15 亿美元

Insight数据库
Aug 06, 2025

8 月 6 日,诺和诺德发布 2025年 H1 财报,上半年营收1549.44 亿丹麦克朗(约合 228.54 亿美元,按平均汇率计算:1 丹麦克朗 = 0.1475 美元,下同),同比增长 18%(按 CER 计算)。中国区收入 99.10 亿丹麦克朗(14.62 亿美元),同比增长 6%。研发投入 219.98 亿丹麦克朗,约合 32.45 亿美元。来源:诺和诺德财报司美格鲁肽上半年销售额为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10